ArticleCureus2026
MRI-Negative Internuclear Ophthalmoplegia: A Diagnostic Challenge Emphasizing Clinical Localization.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Internuclear ophthalmoplegia (INO) is a distinct ocular motility disorder localizing to the medial longitudinal fasciculus (MLF). Because the MLF is a microscopic, highly myelinated tract, small inflammatory lesions can cause significant functional conduction blocks that fall below the resolution threshold of typical 1.5T or 3T MRI. This leads to clinical radiographic dissociation, resulting in a significant diagnostic challenge when pathognomonic physical findings are present despite negative neuroimaging. A 16-year-old female presented with acute binocular diplopia and bilateral INO. Physical examination revealed pathognomonic bilateral failure of adduction, dissociated nystagmus, and impaired convergence. While the brain MRI demonstrated periventricular white matter hyperintensities, it failed to reveal a distinct lesion within the MLF. Despite the lack of definitive radiological localization in the brainstem, the clinical findings were conclusive for a demyelinating process. The patient was treated empirically with high-dose intravenous methylprednisolone to facilitate blood-brain barrier stabilization and address suspected inflammatory demyelination. This case underscores the diagnostic hierarchy in neurology, where pathognomonic physical findings must supersede nonspecific imaging in highly localizing brainstem disorders. Early recognition is vital, especially in pediatric populations where bilateral INO serves as a "red flag" for multiple sclerosis or other central demyelinating events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.